Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for preparing ezetimibe and intermediate thereof

A kind of technology of ezetimibe and compound, applied in the field of medicinal chemistry

Inactive Publication Date: 2013-11-13
SUZHOU VIGONVITA LIFE SCIENCES CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The tricyclic indenoxazole chiral auxiliary agent selected by the present inventor, the full name is (3aS, 8aR)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazole- 2-keto, the structure is This auxiliary agent has been used in many complex total synthesis strategies, such as antiviral drug sinefungin (Sinefungin) (Tetrahedron Lett., 1995,36, p7619) and HIV protease saquinavir (Saquinavir) inhibitor (J .Org.Chem., 1997, 62, p6080), the development has been relatively mature, but this auxiliary agent has never been used in the synthesis of ezetimibe

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing ezetimibe and intermediate thereof
  • Method for preparing ezetimibe and intermediate thereof
  • Method for preparing ezetimibe and intermediate thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1 1-(4-fluorophenyl)-5-((3aS,8aR)-2-carbonyl-2H-indeno[1,2-d]oxazolyl-3(3aH,8H,8aH)- base) pentane-1, the synthesis of 5-dione (compound IV)

[0040]

[0041] Under the protection of nitrogen, 5-(4-fluorophenyl)-5-oxopentanoic acid (Shanghai Kailu Chemical Co., Ltd.) (30g) and diisopropylethylamine (40.8mL, 1.73eq) were dissolved at 0°C in dichloromethane (150ml), then trimethylacetyl chloride (17.6mL, 1.0eq) was added dropwise to the reaction over 30 minutes. Keep stirring the reaction solution at 0°C for about 3 hours, then add (3aS,8aR)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazol-2-one (tri Cycloindenoxazole) (25g, 1.0eq), 4-dimethylaminopyridine (1.745g, 0.1eq) and dry DMF (25ml), warmed to reflux and maintained at this temperature for about 4 hours. Then, after cooling to 10°C, the reaction solution was slowly added to 2N H 2 SO 4(160ml), a solid precipitated out, filtered the precipitate, and dried to obtain 44.5g of 1-(4-fluorophenyl)-5-((3aS, 8aR)...

Embodiment 2

[0042] Example 2 (3aS, 8aR)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-3,3a,8,8a-tetrahydro-2H-indeno[1 , 2-d] Synthesis of oxazolyl-2-one (compound II)

[0043]

[0044] (+)-diisopinepinyl chloride borane heptane solution (Shanghai Feiteng Chemical Co., Ltd.) (69.1ml, 1.2eq, 62%) was added to a solution of compound IV (39g) in tetrahydrofuran (200ml) and kept at Stir at 30°C for 5 hours, then cool to 10°C, add diethylamine (26.5ml, 2.6eq), continue to stir for 2 hours, filter off the precipitate, wash the filter cake with tetrahydrofuran (20ml) and combine the organic phases with water (100ml) The organic phase was washed with water and brine (50ml) and concentrated to give a yellow oil. The oil was dissolved with 110ml of petroleum ether / ethyl acetate=10:1 (v / v), stirred for 14 hours, a white solid precipitated, filtered, and dried to obtain 33.5g of the title compound II, with a yield of 86%. h 1 NMR (300MHz, CDCl 3 ): δ1.82(m, 5H), 2.98(t, 2H), 3.41(s, 3H), 4.68(...

Embodiment 3

[0045] Example 3 (3aS)-3-((2R, 5S)-5-(4-fluorophenyl)-2-((S)-(4-fluorophenylamino)(4-(trimethylsilyloxy Base)phenyl)methyl)-5-(trimethylsilyloxy)pentanoyl)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazole-2- Ketone (Compound I, PG 1 =PG 2 = Trimethylsilyl) Synthesis

[0046] Under nitrogen protection, compound II (2.06g, 5.58mmol) and (E)-4-((4-fluorophenylamino)methyl)phenol (compound III) (2.401g, 11.15mmol) prepared in Example 2, 2.0eq) was added to dry dichloromethane (20ml), the reaction solution was cooled to -5°C, diethylamine (4.9ml, 29.28mmol, 5.25eq) was added slowly, and trimethylchlorosilane (2.7ml, 20.97mmol, 3.76eq), after the addition, the reaction solution was cooled to -25°C to -30°C, and TiCl was added slowly 4 (0.67ml, 6.13mmol, 1.1eq), Ti(OCH(CH 3 ) 2 ) 4 (0.6ml, 0.37mmol), after stirring for half an hour, keep the temperature at -25°C to -30°C, add acetic acid (1.6ml, 27.88mmol, 5.0eq), and continue stirring for half an hour. The reaction solution was ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A preparation method for ezetimibe and intermediates thereof are disclosed. More specifically, compounds shown as the following general formula (I), preparation method, intermediates in the preparation process and use thereof are disclosed. The said compounds are used to prepare ezetimibe.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry and relates to a preparation method of ezetimibe and an intermediate thereof. More specifically, it relates to the compound of general formula I as shown below, its preparation method and intermediates in the preparation process, and the use of the compound of general formula I for preparing ezetimibe (structural formula as follows). Background technique [0002] Ezetimibe (Ezetimibe, the following structural formula), the chemical name is (3R,4S)-1-4-(4-fluorophenyl)-3-(3S)-3-[3-(4-fluorophenyl) )-3-hydroxyphenylpropyl]-4-(4-hydroxyphenyl)-2-azetidinone is a blood lipid-lowering drug that belongs to selective cholesterol absorption inhibitors, which bind to the small intestinal brush border The membrane protein binding on the membrane vesicles inhibits the body's absorption of cholesterol, thereby reducing cholesterol levels and lowering blood lipids. [0003] [0004] Ezetimibe structure ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D263/52C07F7/18C07D205/08
CPCC07D263/52C07D205/08C07F7/1856C07F7/1804
Inventor 朱富强吴明军唐桂军李海泓
Owner SUZHOU VIGONVITA LIFE SCIENCES CO LTD